|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 489/08 | (2006.01) |
| A61K 31/485 | (2006.01) | ||
| A61P 1/10 | (2006.01) | ||
| A61P 25/04 | (2006.01) |
| (11) | Number of the document | 1913001 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06771163.0 |
| Date of filing the European patent application | 2006-05-25 | |
| (97) | Date of publication of the European application | 2008-04-23 |
| (45) | Date of publication and mention of the grant of the patent | 2013-09-04 |
| (46) | Date of publication of the claims translation | 2013-11-25 |
| (86) | Number | PCT/US2006/020233 |
| Date | 2006-05-25 |
| (87) | Number | WO 2006/127899 |
| Date | 2006-11-30 |
| (30) | Number | Date | Country code |
| 684616 P | 2005-05-25 | US |
| (72) |
DOSHAN, Harold, D., US
PEREZ, Julio, US
|
| (73) |
PROGENICS PHARMACEUTICALS, INC.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | (R)-N-metilnaltreksonas, jo sintezės būdai ir jo panaudojimas farmacijai |
| (R)-N-METHYLNALTREXONE, PROCESSES FOR ITS SYNTHESIS AND ITS PHARMACEUTICAL USE |
| Payment date | Validity (years) | Amount | |
| 2018-05-18 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-05-25 |